World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12610000094077
Date of registration: 27/01/2010
Prospective Registration: No
Primary sponsor: Dr Phillip Cowlishaw
Public title: The distribution and duration of the sensory block after a standard and refined ultrasound guided transversus abdominis plane (TAP) block.
Scientific title: A randomised, double blind, pilot study to evaluate the distribution and duration of the sensory block after a standard and refined ultrasound guided transversus abdominis plane (TAP) block.
Date of first enrolment: 01/01/2010
Target sample size: 20
Recruitment status: Recruiting
URL:  https://anzctr.org.au/ACTRN12610000094077.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Australia
Contacts
Name: Phillip Cowlishaw   
Address:  Mater Health Services Raymond Terrace Brisbane Queensland 4101 Australia
Telephone: +61 7 31638646
Email: phillip.cowlishaw@mater.org.au
Affiliation: 
Name: Phillip Cowlishaw   
Address:  Mater Health Services Raymond Terrace Brisbane Queensland 4101 Australia
Telephone: +61 7 31638646
Email: phillip.cowlishaw@mater.org.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: All participants undergoing lower abdominal surgery through a midline incision at the Mater Hospital who are scheduled to receive a TAP block
Exclusion criteria: Pre-existing sensory loss/changes on their abdomen
Participants who have received central neuraxial anaesthesia
Contraindication to TAP block (Participants with a body mass index (BMI) >38, local sepsis, coagulation abnormalities – platelets < 80, international normalised ratio (INR)>1.5, activated thromboplastin time (APTT)>1.5, local anaesthetic allergy, abnormal anatomy)
Children and /or young people (age <18)
People with an intellectual or mental impairment
People whose primary language is other than English
Planned surgical infiltration of local anaesthetic or other regional anaesthetic technique


Age minimum: 18 Years
Age maximum: No limit
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Anaesthesiology - Anaesthetics
Pain;
Pain
Intervention(s)
The aims of the study are to evaluate the duration and distribution of the sensory block after an ultrasound guided TAP block using a standard and refined needling technique. Twenty participants undergoing lower abdominal surgery through lower midline incision will be studied prospectively. Each participant will receive a bilateral TAP block using the refined needling technique on one side of the abdomen and the standard needling technique on the other side. Randomisation will determine which side receives which technique.

The standard technique requires the needle to be inserted medial and parallel to the ultrasound probe. With ultrasound guidance it is directed ‘in plane’ to ensure the tip lies between the internal oblique and transversus abdominis 1-2cm anterior to where the transversus abdominus muscle becomes a fascial extension. To confirm location, 2ml of normal saline can be injected. Once position is satisfactory, 0.5% Ropivacaine is injected in 5ml aliquots with aspiration between injection to a total of 0.75mg/kg. The time required to perform this procedure is 5 to 10 minutes.

The refined technique requires the needle to be inserted more medially compared with the standard technique and directed slightly laterally towards the ultrasound probe. Using ultrasound 'in plane' guidance the needle is positioned in the transversus abdominis plane at its anterior origin and advanced along the plane to ensure at least 5cm of needle is contained within this plane. The tip should still lie 1-2cm anterior to where the transversus abdominus muscle becomes a fascial extension. Hydrodissection with saline may be used to assist needle positioning. Once position is satisfactory, 0.5% Ropivacaine is then injected in 5ml aliquots with aspiration between inj
Primary Outcome(s)
To assess the duration of the TAP block[At 1 hour, 3 hours and then 2 hourly post surgery a blinded researcher will assess the participant for sensory changes to ice and light touch on each side of the abdomen. This will be mapped on a anatomical drawing. This will continue until the researcher cannot elicit any sensory changes.]
Secondary Outcome(s)
To compare the analgesic quality and sensory block in participants who have received a standard needling technique compared with the refined needling technique[At 1 hour, 3 hours and then 2 hourly post surgery a blinded researcher will assess the participant by:-
1. Asking the participant to complete three visual analogue score (VAS) analgesia scores. One for each side of the abdomen and one to compare each side of the abdomen.
2. Any sensory changes to ice and light touch will be mapped on an anatomical drawing. The researcher will cease assessments when no sensory changes can be ellicited]
To assess the distribution of sensory blockade after a TAP block[At 1 hour, 3 hours and then 2 hourly post surgery a blinded researcher will assess the participant for sensory changes to ice and light touch on each side of the abdomen. This will be mapped on a anatomical drawing. This will continue until the researcher cannot elicit any sensory changes.]
Secondary ID(s)
None
Source(s) of Monetary Support
Mater Health Services
Secondary Sponsor(s)
Dr Tim Sampson
Ethics review
Status: Approved
Approval date:
Contact:
Mater Health Services Human Research Ethics Committee
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history